3 Undervalued Pharmaceuticals Stocks for Monday, November 09
Discover the top 3 undervalued Pharmaceuticals stocks for Monday, November 09 based on AAII’s Stock Grades.Rosalio Madrigal
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Michael Rose
Rosalio Madrigal
Michael Rose
Jenna Brashear
| Share Statistics | ARVN | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $423.0 | $421.5 | 37% |
|
| Shares Out (Mil) | 65.4 | 46.9 | 53% |
|
| Institutional Ownership | 97.3% | 82.0% | 73% |
|
| Float (Mil) | 60.4 | 49.2 | 51% |
|
| Beta | 1.80 | 0.68 | 89% |
|
| Avg Daily Volume (000s) | 1,016 | 347 | 70% |
|
| Price Change (52-week) |
(44.0%) | 49.3% | 25% |
|
| Growth | ARVN | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 58.9% | 6.4% | 97% |
|
| Net Income (5yr) | 7.5% | (1.3%) | 51% |
|
| EPS (5yr) | 17.7% | 15.1% | 64 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (47.2%) | (15.0%) | 8% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 11 | 11 | 12 | |
| Current EPS | ($0.767) | $0.159 | ($3.177) | |
| Month Ago EPS | ($0.927) | ($0.137) | ($3.232) | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 1 | 1 | 2 | |
| Three Months Ago EPS | ($0.885) | ($0.068) | ($3.072) | |
| Year/Year Chg | (6.9%) | (113.9%) | 140.1% | |
| Financials | ARVN | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $275 | $275 | 35% |
|
| Net Income (TTM) (Mil) | ($10) | ($11) | 29% |
|
| EPS (TTM) | ($0.147) | ($0.700) | 34% |
|
| Operating Cash Flow (TTM) (Mil) | ($158) | ($7) | 4% |
|
| Net Cash Flow (TTM) (Mil) | ($13) | $1 | 31% |
|
| Long-Term Debt (Q1) (Mil) | $6 | $6 | 25% |
|
| Enterprise Value (Q1) (Mil) | ($65) | $331 | 1% |
|
| Valuation | ARVN | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.82 | 2.08 | 22% |
|
| P/E | na | 20.9 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | ARVN | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 96.7% | 69.5% | 96% |
|
| Net Margin | (3.5%) | 3.6% | 26% |
|
| ROA | (1.3%) | (23.8%) | 35% |
|
| ROE | (1.8%) | (24.2%) | 33% |
|
| Liabilities to Assets | 15.4% | 31.6% | 10% |
|
| F-Score | 5 | 3 | 50% |
|
Arvinas, Inc. did not pass any screens on 11/20/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors